drugset / Trial / NCT00679510

Rosuvastatin in Rheumatoid Arthritis (RORA)

NCT00679510

Phase 2/3 Completed 50 enrolled University of Dundee
RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with rheumatoid arthritis are at increased risk of having cardiovascular deaths. The investigator's study is aimed at looking at the effects of proven cholesterol lowering treatment drug called rosuvastatin in rheumatoid arthritis patients on few cardiovascular markers. Endothelial behaviour improved on treatment.

Timeline

Start
2004-02
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosuvastatin Small molecule 10 mg

Indications